Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03608254 · ClinicalTrials.gov registry record
Acute Effects of Watermelon on Vascular Function and Serum Lycopene
A clinical trial of Vascular Health of Postmenopausal Women, sponsored by University of Alabama, Tuscaloo.
- Completed
- Registry status
- 11
- Enrollment target
- 1
- Study location
NCT03608254: Completed study of Vascular Health of Postmenopausal Women, sponsored by University of Alabama, Tuscaloo.
NCT03608254 is a study of Vascular Health of Postmenopausal Women that has completed, run by University of Alabama, Tuscaloo. The registered enrollment target is 11 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03608254, a study of Vascular Health of Postmenopausal Women, has completed, sponsored by University of Alabama, Tuscaloo.
- COMPLETED
- Registry status
- 11 participants
- Enrollment target
- 1
- Study location
Study Summary
This study aimed to examine the effects of a one-time dose of 100% watermelon juice on circulating lycopene levels and measures of vascular health among a cohort of postmenopausal women.
Primary Outcome
On the testing day, participants reported to the clinic following a 10-hour overnight fast. Blood samples were obtained by standard venipuncture at baseline and two hours after ingestion of a 360 ml dose of 100% pasteurized watermelon juice in order to determine change in serum lycopene levels.
Conditions Studied
Interventions
- OTHER 100% watermelon juice
Study Locations (1)
Alabama
- University of Alabama - Tuscaloosa
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 11 participants |
| Start Date | 2015-11-05 |
| Est. Completion | 2016-12-08 |
What the finished NCT03608254 record still lists
NCT03608254 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 11 participants, a relatively small participant target.
The record links to 1 condition, with Vascular Health of Postmenopausal Women appearing as the primary indexed condition, and to 1 intervention - of which 100% watermelon juice is the first listed.
NCT03608254 reports a single indexed study location in Alabama.
Frequently Asked Questions
What is clinical trial NCT03608254 about?
NCT03608254 is a clinical study titled "Acute Effects of Watermelon on Vascular Function and Serum Lycopene". This study aimed to examine the effects of a one-time dose of 100% watermelon juice on circulating lycopene levels and measures of vascular health among a cohort of postmenopausal women.
What is the current status of trial NCT03608254?
This trial is currently completed. The enrollment target is 11 participants. The study started on 2015-11-05. Estimated completion is 2016-12-08.
What conditions does trial NCT03608254 study?
This clinical trial studies the following conditions: Vascular Health of Postmenopausal Women.
What interventions are being tested in trial NCT03608254?
The interventions under investigation include: 100% watermelon juice (OTHER).
Who is sponsoring clinical trial NCT03608254?
This trial is sponsored by University of Alabama, Tuscaloo, which has 17 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03608254 being conducted?
This trial has 1 study location across Alabama. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03114462 · 11 participants · Phase 1
Trial of Stereotactic HYpofractionateD RadioAblative (HYDRA) Treatment of Laryngeal Cancer
- NCT06039709 · 11 participants · Phase 1
Sonodynamic Therapy in Patients With Recurrent GBM
- NCT06425380 · 11 participants · NA
Pilot Open-Label Trial of Resistant Potato Starch in Patients With Cirrhosis and Overt Hepatic Encephalopathy
- NCT06472661 · 11 participants · Early Phase 1
FUSA With Intratumoral PolyICLC in Regionally Advanced Resectable Melanoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI